TipHub

₹74

▼ -0.97 -1.29%

As of 22 Sept 2026 · delayed

BSE Listed

Concord Drugs Limited (538965)

Volume: 9,775Avg Vol 1W: 4,698Avg Vol 1M: 5,40352W Range:₹61₹92.52
BSE www.concorddrugs.in AI Report
Key Ratios
Checked 4h ago
Market Cap₹97 Cr
Current Price₹74
Previous Close₹74.97
High / Low (52w)₹92.52 / ₹61
Volume9,775
Avg Vol (1W)4,698
Avg Vol (1M)5,403
Stock P/E47.44
Book Value₹35.43
Dividend Yield0%
ROE217.46%
ROA273.73%
Revenue (TTM)—
Revenue Growth—
Profit Margin238.15%
Total Debt—
Shares Outstanding1 Cr
Face Value—
EPS (TTM)₹1.56
P/B2.09
Debt / Equity0.41
50 DMA₹74.68
200 DMA₹77.93
Day change-1.29%
Price Chart
₹74▲ 10.45% · 1Y
₹90₹4165K
2025-09-22
2026-09-22

20-day avg volume: 5K shares

Pros
  • Healthy return on equity of 217.5%.
  • Company is almost debt-free.
Cons
  • Revenue fell 73% YoY.
Quarterly Results
MetricSept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Revenue₹12 Cr₹11 Cr₹10 Cr₹14 Cr₹10 Cr₹17 Cr₹38 Cr₹21 Cr
EBITDA₹1 Cr₹1 Cr₹1 Cr₹1 Cr₹1 Cr₹1 Cr₹1 Cr₹2 Cr
Net Profit₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹1 Cr₹1 Cr
EPS————————
Profit & Loss (Annual)
MetricMar 2025Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Mar 2026Jun 2026
Revenue₹45 Cr₹8 Cr₹13 Cr₹10 Cr₹17 Cr₹79 Cr₹36 Cr₹21 Cr
EBITDA₹3 Cr₹1 Cr₹1 Cr₹1 Cr₹1 Cr₹3 Cr₹1 Cr₹2 Cr
Net Profit₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹1 Cr₹1 Cr₹1 Cr
EPS0.34————0.95——
Balance Sheet
MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets₹56 Cr₹58 Cr₹59 Cr₹65 Cr₹75 Cr
Total Liabilities₹28 Cr₹27 Cr₹25 Cr₹31 Cr₹26 Cr
Equity₹28 Cr₹32 Cr₹34 Cr₹34 Cr₹49 Cr
Total Debt—————
Cash Flow
MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating₹1 Cr₹2 Cr₹1 Cr₹4 Cr₹-5 Cr
Investing₹-2 Cr₹-2 Cr₹-1 Cr₹-2 Cr₹-1 Cr
Financing₹2 Cr₹1 Cr₹0 Cr₹-1 Cr₹7 Cr
Free Cash Flow₹-1 Cr₹1 Cr₹0 Cr₹2 Cr₹-6 Cr
Shareholding
Promoter 45.08% Institutions 0% Public 54.92%
Efficiency & Working Capital
ROCE5.1%
Interest Coverage1.9
Dividend Payout—
Debtor Days113 d
Inventory Days118 d
Payable Days33 d
Cash Conversion Cycle199 d
Working Capital Days231 d
Shareholding Details

As of 2026-06-30

Promoter45.1%
FII0%
DII0%
Institutions0%
Public54.9%
Promoter Pledge0%
No. of Shareholders4,435
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodDec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Nov 2025Dec 2025Mar 2026Jun 2026
Promoters55.4%55.4%55.4%54.4%54.4%54.4%54.4%54.4%45.1%54.4%54.4%45.1%
FIIs0%0%0%0%0%0%0%0%0%0%0%0%
DIIs0%0%0%0%0%0%0%0%0%0%0%0%
Public44.6%44.6%44.6%45.6%45.6%45.6%45.6%45.6%54.9%45.6%45.6%54.9%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders4,0324,7344,7555,0735,0735,2525,1894,7184,5974,5974,4644,435
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202603————
Major Shareholders (>1%)
NameCategoryStakeShares
Nagi Reddy SeelamShareholding of Promoter and Promoter Group23.2%30,60,536
Manojkumarreddy SeelamShareholding of Promoter and Promoter Group13.5%17,78,125
Seelam Koni ReddyShareholding of Promoter and Promoter Group8.4%11,00,543
C SushmithaPublic Shareholding8.4%11,00,000
Anjana BangadPublic Shareholding2.3%3,00,000
Anuradha BangadPublic Shareholding2.3%3,00,000
Pranali BangadPublic Shareholding2.3%3,00,000
Vikas BangadPublic Shareholding2.3%3,00,000
Komal SharmaPublic Shareholding1.6%2,06,900
Ganga Devi LoyaPublic Shareholding1.5%1,94,700
Mohan ThodupunuriPublic Shareholding1.2%1,51,006
Rajender Kumar AgarwalPublic Shareholding1.1%1,48,854
Board of Directors
NameDesignationYear
S Nagi ReddyChairman / Executive Director / M D / Promoter2025
Koni ReddyED / WTD / CFO / Promoter2025
S. Manoj Kumar ReddyWTD & Executive Director2025
K Ramchandra ReddyIndependent Non Exe. Director2025
Summela KasuIndependent Non Exe. Director2025
S. Nagavenkata HareeshIndependent Non Exe. Director2025
Satyam Reddy GopidiIndependent Non Exe. Director2025
NamrathaCompany Sec. & Compli. Officer2025
Segments — Product
SegmentRevenueShare
Pharmaceutical Formulations₹76 Cr100%
Segments — Geography
RegionRevenueShare
India₹76 Cr100%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2026₹10151313
Corporate Actions
TypeDateValueRemark
forthcoming2026-08-10Board Meetings—
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
202521101014
2025080109
2025230005
Insider / Designated-Person Trades

3 recent disclosure(s)

S Manoj Kumar reddyAcquisition · 1,50,000
S Koni ReddyAcquisition · 1,50,000
S Nagi ReddyAcquisition · 2,00,000
Substantial Acquisitions (SAST)

3 disclosure(s)

Pref. Allotment20/11/2025 · 5,00,000
Pref. Allotment20/11/2025 · 5,00,000
Pref. Allotment20/11/2025 · 5,00,000
Company Information
Incorporated1995
ChairmanS Nagi Reddy
AuditorPundarikashyam and Associates
Investor Email[email protected]
🌐 www.concorddrugs.in ↗

📍 Survey No 249 Brahmanapally V, Hayathnagar M, Ranga Reddy, Telangana, 501511

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Mercantile VenturesSonal MercantileAbhinav Leasing & Finance Ltd.Genus Paper & BoardsMinda CorporationMercury Laboratories LimitedWardwizard Innovations & Mobility Ltd.Shree Securities Ltd.Talbros Engineering LimitedSAR Auto Products LimitedPurohit Construction LimitedJayatma Enterprises LimitedAll “53” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search